Gilead has gotten a new HIV preventive treatment, Yeztugo, approved, which consists of two injections a year, promising more effective prevention.
Lara Maior
Current Affairs
Foto Gilead Pharma
Always see our news on Google
Yeztugo, a drug developed by Gilead, has been authorized in the United States as a preventive treatment against HIV. It requires only two injections a year, unlike current treatments that require daily pills. While the treatment could revolutionize the fight against the AIDS epidemic, cost remains a crucial issue, with an estimated annual price tag of about $25,000. UNAIDS director Winnie Byanyima emphasized the importance of making the drug affordable to have a real impact in the fight against AIDS.
Sources
Tratament promiţător împotriva HIV-SIDA. Producătorii promit prețuri accesibil
Statele Unite autorizează un nou tratament preventiv, foarte promiţător, împotriva HIV, virusul care cauzează SIDA
FDA approves first twice-yearly injection that prevents HIV infection
US approves promising preventive HIV treatment
Groundbreaking twice-a-year HIV drug that could stop transmission approved
Latest News
22:57
Traian Băsescu says that AUR "has reached the end of its growth potential" and will have to explain "the money it gave to television stations"
22:50
Paramount Skydance and Warner Bros Discovery will form Skydance after the completion of a $110 billion deal
22:36
The sixth day of protests at the Central Detention Center: Supporters of Călin Georgescu demand his release
22:14
Traian Băsescu, regarding the government crisis: “They have no solution left except an independent prime minister”
21:56
Britain’s Green Party voted to classify Zionism as racism / Israel accuses the party of legitimizing terrorism
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
